It is known that platelet aggregation and blood coagulation are common risk factors for pathologic phenomena in cardiovascular disease. Antiplatelet drugs, such as theophylline and verapamil, decrease the concentration of cytosolic free Ca 2ϩ by elevating the level of cyclic-adenosine monophosphate (cAMP).
by elevating the level of cyclic-adenosine monophosphate (cAMP).
2) Vasodilators, such as molsidomine, nitroprusside, and nitroglycerine, inhibit the activation of platelets by elevating the cyclic-guanosine monophosphate (cGMP) concentration. 3, 4) Egg yolk proteins have been recognized to be beneficial to health for a long time. However, there are adverse reports that the proteins of egg yolk are composed of allergens such as lipovitellenin and livetin. 5, 6) Another harmful substance of hen eggs is cholesterol, which affects serum cholesterol levels. Egg cholesterol is known to be contained only in the yolk. 7) Interestingly, in our studies, we found that proteins from hen egg yolk (EP) did not contain allergenic proteins and cholesterol (Fig. 1, 2B-5 ). Accordingly, we investigated whether EP has antiplatelet and anticoagulation effects compared with those of theophylline and molsidomine, which elevate cAMP and cGMP, respectively. 
MATERIALS AND METHODS

Materials
Preparation of Protein Extracts from Hen Egg Yolks
Hen eggs were purchased from a local market and the yolks were collected. A total 20 g of egg yolk was homogenized with extraction solvents (chloroform/methanol 2 : 1, v/v) using the method of Folch et al., 8) and then extracted three times with extraction solvents using an extraction mixer (Lab-Line Instruments, Inc.). After centrifugation, the lower layer was collected, frozen at Ϫ80°C, and then lyophilized for 24 h. This dehydrated substance was dissolved and extracted in solvent (chloroform/distilled water 1 : 1, v/v). After centrifugation, the chloroform layer and aqueous layer were separated. The aqueous layer was filtered with a centrifuge filter device (Amicon Centricon YM-10, Millipore, Beford, MA, U.S.A.). The lower layer was frozen at Ϫ80°C and then lyophilized for 24 h. This dehydrated substance was dissolved in distilled water when assayed.
Separation and Identification of EP EP containing an equal volume of sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) buffer (5% mercaptoethanol, 2% SDS, 10% glycerol, 0.0625 M Tris, 0.01% bromphenol blue, pH 6.8) was boiled for 5 min to denature the proteins completely. The proteins were separated by SDS-PAGE (17%, 1.0 mm gel) according to the method of Laemmli.
9)
Separated proteins were stained with silver stain (Silver Stain Plus, Bio-Rad Laboratories) and dried. The relative intensity of protein bands was analyzed using SigmaGel TM Gel Analysis Software (Jandel, Scientific Software, U.S.A.). Molecular weight standards were used as low-range protein size markers in silver stain.
Preparation of Human Washed Platelets Blood from healthy human volunteers was anticoagulated by 10% ACD solution (0.8% citric acid, 2.2% sodium citrate, 2.45% glucose). Platelet-rich plasma (PRP) was obtained by centrifugation at 340ϫg for 10 min. The PRP was recentrifuged at 1300ϫg for 10 min to obtain platelet pellets, and the platelets were washed twice with washing buffer (138 mM NaCl, 2.7 mM KCl, 12 mM NaHCO 3 , 0.36 mM NaH 2 PO 4 , 5.5 mM glucose, 1 mM EDTA, pH 6.5). Washed platelets were suspended in suspension buffer (138 mM NaCl, 2.7 mM KCl, 12 mM NaHCO 3 , 0.36 mM NaH 2 PO 4 , 5.5 mM glucose, 0.49 mM MgCl 2 , 5.5 mM glucose, pH 6.9) to a final concentration of 5ϫ10 8 platelets/ml. All the procedures above were carried out at 25°C to avoid platelet aggregation during cooling.
Measurement of Human Platelet Aggregation The washed platelets (10 8 /ml) were preincubated in a siliconized cuvette with gentle stirring for 3 min at 37°C in the presence of 2 mM CaCl 2 with or without testing materials, and then stimulated with 10 mg of collagen/ml for 5 min with gentle stirring. Platelet aggregation was monitored using an aggre-gometer (Chrono-Log) in terms of the increase in light transmission. The suspension buffer was used as a reference (100% transmission).
Measurement of PT and APTT Citrated platelet-poor plasma (PPP) was prepared by centrifuging the blood remaining after the removal of PRP at 1300ϫg for 10 min. The PPP (0.1 ml) was preincubated in a two-channel coagulator (KG Behnk Elektronik GMBH & Co., Germany) cup (BioMérieux, 95-662) with gentle stirring for 1 min at 37°C. PT was determined as the time interval between the addition of PT reagent (0.1 ml) to the PPP and the formation of a fibrin clot. After preincubation for APTT measurement, 0.1 ml of APTT reagent was added to the PPP and incubated for 3 min at 37°C. Following incubation, 0.1 ml of 25 mM CaCl 2 was rapidly added to the PPP solution containing APTT reagent. APTT was determined as the time required to form a fibrin clot.
Identification of Lipids in EP The phospholipids were separated by two-step single-dimensional thin-layer chromatography. 10) Plates were first developed with chloroform/ acetone/methanol/water/acetic acid (100 : 100 : 50 : 10 : 4, v/v), dried in vacuo for 30 min at room temperature, and redeveloped in the same direction with chloroform/methanol/ acetic acid/water (180 : 150 : 30 : 10, v/v). On the other hand, cholesterol was separated by one-step single-dimensional thin-layer chromatography. Plates were developed with hexane/diethylether/acetic acid (80 : 20 : 1, v/v). To identify the spots of separated compounds, the plates were air-dried and then exposed to I 2 vapor.
Determination of Amino Acids in EP Polypeptides (60.21 mg) were hydrolyzed in the presence of 0.1% phenol and 5.7 M HCl at 110°C for 24 h and neutralized. The neutralized samples were filtered with 0.02 M sodium citrate and then analyzed with amino acid analyzer (Pharmacia LKB).
Determination of Protein Content
The contents of protein were measured by the method of Lowry et al. Fig. 1 , EP separated by SDS-PAGE mainly consists of four polypeptides, with molecular weights of 6.5, 14.3, 24.5, and 28.9 kDa. The protein content in each band was calculated based on the relative density to the content (7.67 mg) of proteins applied in SDS-PAGE. Polypeptides of the highest content (2.76 mg protein) among the four polypeptides had a molecular weight of 14.3 kDa, which corresponded to 36% of total proteins. It is inferred that polypeptides in EP have different molecular weights from polypeptides, such as lipovitellin (MW, 400 kDa), lipovitellenin (MW, 4800 kDa), phosvitin (MW, 36 kDa), and livetin (MW, 180 kDa). 12) EP consisted of seven amino acids: aspartic acid, glutamic acid, glycine, alanine, valine, leucine, and lysine. In special, it was observed that lysine, one of the essential amino acids, was a major amino acid in EP (Table 1) . Lysine in EP contained 70.9% of total amino acids. Phospholipids in egg yolk are important components of lipoproteins, such as lipovitellin and lipovitellenin. The major phospholipids such as phosphatidylcholine (PC) and phosphatidylethanolamine (PE) are known to be contained in egg yolk. Because these phospholipids have emulsifying properties, it was investigated Concentrations of amino acids in EP were analyzed as described in Materials and Methods. whether PC and PE were present in our prepared EP. As shown in Fig. 2 , PC and PE used as standards were observed at 0.26 and 0.71 of Rf on TLC, respectively ( Fig. 2A-1, 2) . PC, PE and other lipids, however, were not observed in EP ( Fig. 2A-3) . These results suggest that lipoproteins such as lipovitellin and lipovitellenin are not contained in EP. Cholesterol is known to be present in egg yolk. 13) As shown in Fig. 2 , cholesterol used as a standard was observed at Rf 0.05 on TLC (Fig. 2B-4) . In particular, when cholesterol plus EP was also developed on TLC, only the cholesterol standard was observed at Rf 0.05 on TLC (Fig. 2B-6 ). However, cholesterol was not observed in EP (Fig. 2B-5) .
11) RESULTS
Characteristics of EP As shown in
Inhibitory Effect of EP on Platelet Aggregation When human platelets (10 8 /ml) were stimulated with collagen (10 mg/ml), 65% aggregation occurred (Table 2) . However, EP inhibited the platelet aggregation induced by collagen in a dose-dependent manner. Elevation of the cytosolic free Ca 2ϩ concentration is essentially required for platelet aggregation. Antiplatelet drugs such as molsidomine and theophylline elevate the levels of cGMP and cAMP, 14) respectively. The inhibitory mode of both cGMP and cAMP is involved in the decrease in cytosolic free Ca 2ϩ concentration.
14)
Accordingly, we used molsidomine to increase the cGMP level by inhibiting cGMP-specific phosphodiesterase and used theophylline to increase the cAMP level by inhibiting cAMP-specific phosphodiesterase. As shown in Table 2 , the platelet aggregation (43.8Ϯ5.6%) induced by collagen in the presence of molsidomine (10 mM) was low as compared with that (65.0Ϯ1.3%) induced by collagen alone (10 mg/ml). This means that molsidomine increases the level of cGMP to inhibit the platelet aggregation induced by collagen, which decreases the level of cGMP. However, the platelet aggregation (17.5Ϯ2.7, 3.8Ϯ0.6%, respectively) induced by collagen in the presence of both molsidomine (10 mM) and EP (5, 10 mg protein/ml) were inhibited by 60% and 91.3% as compared with that (43.8Ϯ5.6%) induced by collagen in the presence of molsidomine without EP, respectively (Table 2 ). These results suggest that EP might have a synergistic effect with molsidomine and have an inhibitory effect on cGMP-specific phosphodiesterase to increase the level of cGMP in collageninduced platelet aggregation. When platelets were stimulated by collagen in the presence of theophylline (10 mM), the platelet aggregation (31.3Ϯ4.0%) was inhibited by 51.8% as compared with that (65.0Ϯ1.3%) induced by collagen without theophylline. This means that theophylline enhances the level of cAMP to inhibit the platelet aggregation induced by collagen. 15) On the other hand, the platelet aggregation (7.5Ϯ1.3, 3.8Ϯ0.3%, respectively) induced by collagen with both EP (5, 10 mg protein/ml) and theophylline (10 mM) was inhibited by 76.0 and 87.9% as compared with that (31.3Ϯ4.0%) induced by collagen in the presence of theophylline without EP, respectively (Table 2 ). These results suggest that EP might have a synergistic effect with theophylline and have an inhibitory effect on cAMP-specific phosphodiesterase to increase the level of cAMP in collageninduced platelet aggregation. Thus our results demonstrate that the inhibition of platelet aggregation by EP may be due to the increase in levels of cGMP and cAMP.
Effect on Blood Coagulation Platelet aggregation is dependent on the coagulation factors surrounding the platelets. 16) PT is defined as the time interval between the addition of thromboplastin to plasma and the formation of a fibrin clot. PT is dependent on coagulation factors II, V, VII, and X. As shown in Table 3 , PT was prolonged by 37.9Ϯ0.4 and 73.9Ϯ0.9 s in the presence of 50 and 100 mg EP/ml, which were 3.2-fold and 6.3-fold as compared with the control value (11.7Ϯ0.2 s), respectively. It is suggested that EP may prolong the PT by inhibiting the formation of fibrin clots in the presence of thromboplastin with coagulation factors II, V, VII, and X. APTT is defined as the blood coagulation time in the intrinsic pathway. Both intrinsic and extrinsic thromboplastin convert prothrombin to thrombin to form a fibrin clot. APTT is dependent on coagulation factors VIII and IX. As shown in Table 3 , APTT was prolonged by 224.0Ϯ0.3 s in the presence of 50 mg EP/ml, which was 5.5-fold as compared with the control value (40.5Ϯ0.5 s). Moreover, APTT was prolonged unlimitedly in the presence of 100 mg EP/ml, which completely inhibited the formation of a fibrin clot. These results suggest that EP may prolong APTT unlimitedly by inhibiting the formation of fibrin clots in the presence of thromboplastin with coagulation factors VIII and IX. Thus the results suggest that EP, which inhibits platelet aggregation (Table 2) , may have an anticoagulative effect by inhibiting the formation of fibrin clots in the presence of coagulation factors. 1390 Vol. 26, No. 10 Washed human platelets were preincubated with 0, 5, or 10 mg protein/ml EP, in the presence of buffer, molsidomine (10 mM), or theophylline (10 mM) for 3 min at 37°C and then stimulated with collagen (10 mg/ml). Platelet aggregation was recorded as the increase in light transmission. Inhibition rate (%) was calculated based on the collagen-induced aggregation rate (%). Data are expressed as meanϮS.D. (nϭ3). * pϽ0.01 compared with that of collagen-induced aggregation. * * pϽ0.01 compared with that of collagen (10 mg/ml) plus molsidomine (10 mM)-induced aggregation. * * * pϽ0.01 compared with that of collagen (10 mg/ml) plus theophylline (10 mM)-induced aggregation. 
DISCUSSION
The molecular weights of EP prepared from hen egg yolk are different from lipovitellin (MW, 400 kDa), lipovitellenin (MW, 4800 kDa), phosvitin (MW, 36 kDa) and livetin (MW, 180 kDa). 12) Because PC and PE, the major phopholipids of lipoproteins such as lipovitellin and lipovitellenin, 17) are not contained in EP (Fig. 2) , it is inferred that EP is different from lipovitellin and lipovitellenin. Phosvitin from egg yolk is known to contain serine, a major amino acid, and tryptophan or tyrosine, a minor amino acid. 18) As shown in Table 1 , because serine, tryptophan, and tyrosine are not contained in our EP, it is suggested that EP is also different from phosvitin. Even though it is assumed that EP is different from lipovitellin, lipovitellenin, phosvitin, and livetin, 13) small amounts of phosphorus and hexose were observed in EP (data not shown). At present, unfortunately it has not been clearly elucidated whether phosphorus and hexose are bound in a specific amino acid of EP. Antiplatelet drugs such as molsidomine and theophylline elevate the levels of cGMP and cAMP, respectively, and decrease the concentration of cytosolic free Ca 2ϩ . [2] [3] [4] It was reported that polyamines such as spermine, spermidine, putrescine, lysine, and arginine inhibit the platelet aggregation induced by collagen, ADP, or thrombin. [19] [20] [21] The inhibitory effect of polyamines is due to the decrease in cytosolic free Ca 2ϩ concentration. 22) In this investigation, it was observed that EP contained large amounts of lysine (Table 1) . If polyamines also inhibit platelet aggregation by decreasing cytosolic free Ca 2ϩ concentration, 22) it is possible that EP inhibits the platelet aggregation by lysine in EP, and lysine-rich EP (Table 1 ) may elevate the levels of cGMP and cAMP to decrease the collagenelevated cytosolic free Ca 2ϩ concentration. Because EP has a synergistic effect with molsidomine, an inhibitor of cGMPspecific phosphodiesterase, and theophylline, an inhibitor of cAMP-specific phosphodiesterase, on collagen-induced platelet aggregation, it is inferred that EP acts in a similar mechanism with theophylline or molsidomine on the inhibition of platelet aggregation. The cytosolic free Ca 2ϩ concentration elevated by agonists activates phospholipase C to release arachidonic acid (20 : 4) from membrane phospholipids. 23 ) Thromboxane A 2 (TXA 2 ), a potent platelet-aggregating agent, is generated from 20 : 4. 23) If EP inhibited platelet aggregation synergistically with molsidomine or theophylline, which decreases the cytosolic free Ca 2ϩ concentration in platelets (Table 2) , the possibility cannot be excluded that the production of TXA 2 is decreased by EP. Both PT and APTT were potently prolonged by EP in a dose-dependent manner (Table 3) . These results suggest that EP inhibits the formation of fibrin clots, which are generated in a region common to that for platelet aggregation. It is inferred that EP might regulate the balance between antiplatelet activities and anticoagulant activities. It is not evident which peptides in EP are responsible for the inhibitory action against platelet aggregation. Fortunately, it was observed that EP was composed of polypeptides with molecular weights of 6.5, 14.3, 24.5, and 28.9 kDa, which differed from those of livetin (MW, 180 kDa) and lipovitellenin (MW, 4800 kDa) in egg yolk. 5, 6, 24) On the other hand, if the inhibition of collagen-induced platelet aggregation by EP was due to the action of phosvitin (MW, 36 kDa), collagen-induced platelet aggregation would be inhibited only by phosvitin. However, the platelet aggregation induced by collagen was not inhibited in the presence of phosvitin (Table 4) , and phosvitin was not observed upon SDS-PAGE of EP (Fig. 1) . In conclusion, it is suggested that peptides in EP were different from the proteins phosvitin, lipovitellin, lipovitellenin, and livetin in egg yolk, and that EP might be used as a potent modulator by inhibiting platelet aggregation and blood coagulation. Washed human platelets were preincubated in the presence or absence of phosvitin for 3 min at 37°C and then stimulated with collagen (10 mg/ml). The subsequent response to stimulation with collagen (10 mg/ml) was recorded as the increase in light transmission. The inhibition rate (% of control) was calculated based on the collageninduced aggregation rate (%). Data are expressed as meanϮS.D. (nϭ3). * pϽ0.01 compared with collagen-induced aggregation.
